What amount sold does CATARIA LONG/SHORT EQUITY FUND LP report in Form D filings?

The latest linked filings report $34.7M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was CATARIA LONG/SHORT EQUITY FUND LP's most recent SEC filing?

CATARIA LONG/SHORT EQUITY FUND LP's most recent Form D filing was on 2026-07-15.

How many investors does CATARIA LONG/SHORT EQUITY FUND LP have?

The most recent Form D filing lists 39 investor(s).

CATARIA LONG/SHORT EQUITY FUND LP

CIK: 0001750944·Pooled Investment Fund·BOSTON, MA·Limited Partnership

Reported Sold

$34,695,096

Total Filings

Identified Offerings

Last Filed

Jul 15, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Jul 15, 2026Form D/A — Amendment

Reported sold: $34,695,096 · Target: Indefinite

Rule 506(b)·39 investors·Section 3(c), Section 3(c)(7)

Jul 21, 2025Form D/A — Amendment

Reported sold: $34,695,096 · Target: Indefinite

Rule 506(b)·39 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold

Jul 10, 2024Form D/A — Amendment

Reported sold: $34,173,616 · Target: Indefinite

Rule 506(b)·39 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors, Exemptions

Jul 17, 2023Form D/A — Amendment

Reported sold: $29,693,664 · Target: Indefinite

Rule 506(b)·32 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold

Jul 25, 2022Form D/A — Amendment

Reported sold: $23,755,960 · Target: Indefinite

Rule 506(b)·32 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jul 14, 2021Form D/A — Amendment

Reported sold: $20,059,009 · Target: Indefinite

Rule 506(b)·19 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold

Jul 15, 2020Form D/A — Amendment

Reported sold: $17,559,009 · Target: Indefinite

Rule 506(b)·19 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Aug 23, 2018Form D — New notice

Reported sold: $15,159,009 · Target: Indefinite

Rule 506(b)·18 investors·Section 3(c), Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

88%

Latest reported sold across 1 identified offering

$34,695,096

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Ning Wang

Related Person

Appears on 7 filings

Harry Sun

Related Person

Appears on 7 filings

Cataria Capital Management LP

Related Person

Appears on 7 filings

Cataria Capital GP LLC

Related Person

Appears on 7 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 15, 2026	Amendment	Indefinite	$34,695,096	39
Jul 21, 2025	Amendment	Indefinite	$34,695,096	39
Jul 10, 2024	Amendment	Indefinite	$34,173,616	39
Jul 17, 2023	Amendment	Indefinite	$29,693,664	32
Jul 25, 2022	Amendment	Indefinite	$23,755,960	32
Jul 14, 2021	Amendment	Indefinite	$20,059,009	19
Jul 15, 2020	Amendment	Indefinite	$17,559,009	19
Aug 23, 2018	New	Indefinite	$15,159,009	18

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AVSF - Integrated Biosciences 2026, LLC

Pooled Investment Fund

Offering target: Indefinite

Filed Nov 5, 2026